Application of tangent-arc technology for deep inspiration breath-hold radiotherapy in left-sided breast cancer. 2023

Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.

To explore the advantages of dosimetry and the treatment efficiency of tangent-arc technology in deep inspiration breath-hold radiotherapy for breast cancer. Forty patients with left-sided breast cancer who were treated in our hospital from May 2020 to June 2021 were randomly selected and divided into two groups. The first group's plan was a continuous semi-arc that started at 145° ( ± 5°) and stopped at 325° ( ± 5°). The other group's plan, defined as the tangent-arc plan, had two arcs: the first arc started at 145° ( ± 5°) and stopped at 85° ( ± 5°), and the second arc started at 25° ( ± 5°) and stopped at 325° ( ± 5°). We compared the target dose, dose in organs at risk (OARs), and treatment time between the two groups. The target dose was similar between the continuous semiarc and tangent-arc groups. The V5 of the right lung was significantly different between the two groups (Dif 5.52, 95% confidence interval 1.92-9.13, t=3.10, P=0.004), with the patients in the continuous semi-arc and tangent-arc groups having lung V5 values of (9.16 ± 1.62)%, and (3.64 ± 0.73)%, respectively. The maximum dose to the spinal cord was (1835.88 ± 222.17) cGy in the continuous semi-arc group and (599.42 ± 153.91) cGy in the tangent-arc group, yielding a significant difference between the two groups (Dif 1236.46, 95% confidence interval 689.32-1783.6, t=4.57, P<0.001). The treatment times was (311.70 ± 60.45) s for patients in the continuous semi-arc group and (254.66 ± 40.73) s for patients in the tangent-arc group, and there was a significant difference in the mean number of treatment times between the two groups (Dif 57.04, 95% confidence interval 24.05-90.03, t=3.5, P=0.001). Both the continuous semi-arc and tangent-arc plans met the clinical prescription dose requirements. The OARs received less radiation with the tangent-arc plan than the continuous semi-arc plan, especially for the lung (measured as V5) and the spinal cord (measured as the maximum dose). Tangent-arc plan took significantly less time than the continuous semi-arc, which can greatly improve treatment efficiency. Therefore, tangent-arc plans are superior continuous semi-arc plans for all cases.

UI MeSH Term Description Entries

Related Publications

Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
August 2012, Journal of medical imaging and radiation oncology,
Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
January 2022, Frontiers in oncology,
Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
January 2021, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
January 2022, Journal of X-ray science and technology,
Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
November 2018, Radiation oncology (London, England),
Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
July 2015, Journal of applied clinical medical physics,
Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
June 2017, Acta oncologica (Stockholm, Sweden),
Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
January 2017, Tumori,
Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
May 2018, Radiation oncology (London, England),
Yucheng Li, and Wenming Zhan, and Yongshi Jia, and Hanchu Xiong, and Baihua Lin, and Qiang Li, and Huaxin Liu, and Lingyun Qiu, and Yinghao Zhang, and Jieni Ding, and Chao Fu, and Weijun Chen
August 2021, Clinical breast cancer,
Copied contents to your clipboard!